raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:280229

Pelizaeus-Merzbacher disease in female carriers

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
X-linked recessive
Age of onset
Adult
Status
active

Pelizaeus-Merzbacher disease (PMD) in female carriers is the presentation of PMD in some women carrying mutations in the <i>PLP1</i> gene (Xq22).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPelizaeus-Merzbacher disease in female carriers
frMaladie de Pelizaeus-Merzbacher chez les femmes porteuses
dePelizaeus-Merzbacher-Krankheit, weibliche Überträgerinnen
esEnfermedad de Pelizaeus-Merzbacher en mujeres portadoras
itMalattia di Pelizaeus-Merzbacher nelle donne portatrici
nlZiekte van Pelizaeus-Merzbacher bij vrouwelijke dragers
ptDoença de Pelizaeus-Merzbacher em portadores do sexo feminino
plChoroba Pelizaeusa i Merzbachera u kobiet nosicielek
csPelizaeusova-Merzbacherova nemoc u žen přenašečekPelizaeus-Merzbacherova nemoc u žen přenašeček
ukХвороба Пеліцея-Мерцбахера у жінок-носіїв
zh女性携带的佩-梅病
trKadın taşıyıcılarda Pelizaeus-Merzbacher hastalığı

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM312080NTBTvalidated
ICD-10E75.2NTBTattributedvalidated
ICD-118A44.0NTBTindexvalidated
MONDO0017224Evalidated
UMLSC5438815Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PLP1Disease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

28 annotations · validated 2020-10-07
HPOTerm (as annotated by Orphanet)Diagnostic
Occasional (29-5%)
HP:0001273Abnormal corpus callosum morphology
HP:0002167Abnormality of speech or vocalization
HP:0010936Abnormality of the lower urinary tract
HP:0030784Anomia
HP:0003487Babinski sign
HP:0003429CNS hypomyelination
HP:0032044Decreased vigilance
HP:0000490Deeply set eye
HP:0002376Developmental regression
HP:0001288Gait disturbance
HP:0002197Generalized-onset seizure
HP:0001510Growth delay
HP:0032588Hand apraxia
HP:0000666Horizontal nystagmus
HP:0030890Hyperintensity of cerebral white matter on MRI
HP:0001347Hyperreflexia
HP:0000316Hypertelorism
HP:0001252Hypotonia
HP:0002540Inability to walk
HP:0002061Lower limb spasticity
HP:0001268Mental deterioration
HP:0011800Midface retrusion
HP:0011342Mild global developmental delay
HP:0011343Moderate global developmental delay
HP:0000011Neurogenic bladder
HP:0007413Nevus flammeus of the forehead
HP:0000639Nystagmus
HP:0002313Spastic paraparesis

Annotation source: 26279330[PMID]_21623770[PMID]_25831654[PMID]

7

Sources for this card